NCT00005860
- Conditions
- Adenocarcinoma, Adenocarcinoma, Mucinous, Adenoma, +71 more
- Locations
-
- Memorial Sloan-Kettering Cancer Center New York, United States
Clinical trial condition
Neoplasms, Unknown Primary
Explore clinical trials studying Neoplasms, Unknown Primary. Study availability and eligibility vary by location and protocol.
75 public trials
13 recruiting studies
Neoplasms, Unknown Primary trial results
NCT00010023
- Conditions
- Adenocarcinoma, Appendiceal Neoplasms, Bile Duct Diseases, +70 more
- Locations
-
- NYU Cancer Institute at New York University Medical Center New York, United States
NCT00003548
- Conditions
- Adenocarcinoma, Adnexal Diseases, Anus Diseases, +75 more
- Locations
-
- NYU School of Medicine's Kaplan Comprehensive Cancer Center New York, United States
Completed
Bevacizumab and Erlotinib in the Treatment of Patients With Carcinoma of Unknown Primary Site
NCT00193622
- Conditions
- Neoplasm Metastasis, Neoplasms, Neoplasms, Unknown Primary, +3 more
- Locations
-
Not specified
NCT00006361
- Conditions
- Carcinoma, Carcinoma of Unknown Primary, Carcinoma, Squamous Cell, +23 more
- Locations
-
- Memorial Sloan-Kettering Cancer Center New York, United States